Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07149207 · ClinicalTrials.gov registry record · Phase 2
Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors
A Phase 2 study, sponsored by Medical University of South Carolina.
- Recruiting
- Registry status
- Phase 2
- Development phase
- 30
- Enrollment target
NCT07149207 is a Phase 2 study that is actively recruiting participants, run by Medical University of South Carolina. The registered enrollment target is 30 participants.
The verdict
NCT07149207, a Phase 2 study, is actively recruiting participants, sponsored by Medical University of South Carolina.
- RECRUITING
- Registry status
- Phase 2
- Development phase
- 30 participants
- Enrollment target
Study Summary
This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care visits along with administration of ICG dye and imaging during surgery. Participation in this study will last approximately 6 weeks.
Interventions
- DRUG Indocyanine Green (ICG)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-05-04 |
| Est. Completion | 2029-04-07 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07149207
The ClinicalTrials.gov registry entry for NCT07149207 describes a study currently listed as recruiting, categorized as Phase 2. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Indocyanine Green (ICG) is the first listed.
NCT07149207 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07149207 about?
NCT07149207 is a clinical study titled "Intraoperative Molecular Imaging Using ICG for Head and Neck Tumors". This study is for adult patients with head and neck cancer who are at risk of recurrence. The purpose of this study is to evaluate whether the use of Indocyanine Green (ICG) dye allows for better identification of tumor tissue during surgical procedures. Participation will include standard of care v...
What is the current status of trial NCT07149207?
This trial is currently recruiting. It is a Phase 2 study. The enrollment target is 30 participants. The study started on 2026-05-04. Estimated completion is 2029-04-07.
What interventions are being tested in trial NCT07149207?
The interventions under investigation include: Indocyanine Green (ICG) (DRUG).
Who is sponsoring clinical trial NCT07149207?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.